Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Proffered Paper Session 1

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange
Michael Burns
Vanderbilt University School of Medicine, Nashville, TN, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6-- Reactivating Rb in cancer
Sunkyu Kim
Novartis Institutes for Biomedical Research, Cambridge, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
Selective sensitization of mutant K-Ras cancer cells to DNA damage based therapies by targeting wild type H- and N-Ras
Elda Grabocka
NYU Langone Medical Center, New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine Hutchinson
Vanderbilt University, Nashville, TN, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 5:30 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4